My Account Log in

4 options

Accelerating the development of biomarkers for drug safety : workshop summary / Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

EBSCOhost Academic eBook Collection (North America) Available online

View online

Ebook Central Academic Complete Available online

View online

NCBI Bookshelf Available online

View online

National Academies Press Available online

View online
Format:
Book
Conference/Event
Author/Creator:
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Contributor:
Giffin, Robert B.
Olson, Steve, 1956-
Robinson, Sally.
National Research Council (U.S.). Planning Committee for Assessing and Accelerating the Development of Biomarkers for Drug Safety : a Workshop.
Conference Name:
Assessing and Accelerating the Development of Biomarkers for Drug Safety. Workshop (2008 : Washington, D.C.)
Language:
English
Subjects (All):
Biochemical markers--Congresses.
Biochemical markers.
Drugs--Safety measures--Congresses.
Drugs.
Drugs--Testing--Congresses.
Physical Description:
1 online resource (99 p.)
Edition:
1st ed.
Place of Publication:
Washington, D.C. : National Academies Press, c2009.
Language Note:
English
Summary:
"Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a more focused and rational pathway to drug development. On October 24, 2008, the IOM's Forum on Drug Discovery, Development, and Translation held 'Assessing and Accelerating Development of Biomarkers for Drug Safety,' a one-day workshop, summarized in this volume, on the value of biomarkers in helping to determine drug safety during development."--Publisher's website.
Contents:
Overview Of key issues
Cardiac safety biomarkers
Assessing and predicting kidney safety
Biomarkers of acute idiosyncratic hepatocellular injury in clinical trials
Future considerations.
Notes:
Bibliographic Level Mode of Issuance: Monograph
Includes bibliographical references (p. 55-57).
ISBN:
0-309-14231-8
1-282-27265-9
9786612272653
0-309-13125-1
OCLC:
427878159

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account